Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial

被引：0
|
作者：
Lauring, B. [1 ]
Eldor, R. [1 ]
Liu, J. [2 ]
Dagogo-Jack, S. [3 ]
Amorin, G. [4 ]
Johnson, J. [1 ]
Hille, D. [5 ]
Huyck, S. [1 ]
Golm, G. [1 ]
Terra, S. [6 ]
Mancuso, J. [7 ]
Engel, S. S. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Chicago, IL USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[4] MSD Argentina, Buenos Aires, DF, Argentina
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Pfizer Inc, Andover, MA USA
[7] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
181
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy-104-Week VERTIS MET Trial
    Gallo, Silvina
    Charbonnel, Bernard
    Goldman, Allison
    Shi, Harry
    Huyck, Susan
    Darekar, Amanda
    Lauring, Brett
    Terra, Steven
    DIABETES, 2018, 67
  • [32] Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
    Wilding, J. P. H.
    Charpentier, G.
    Hollander, P.
    Gonzalez-Galvez, G.
    Mathieu, C.
    Vercruysse, F.
    Usiskin, K.
    Law, G.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1267 - 1282
  • [33] A randomized clinical trial of the safety and efficacy of sitagliptin in patients with type 2 diabetes mellitus inadequately controlled by acarbose alone
    Wang, Weiqing
    Ning, Guang
    Ma, Jianhua
    Liu, Xiaomin
    Zheng, Shaoxiong
    Wu, Fan
    Xu, Lei
    O'Neill, Edward A.
    Fujita, Kenji P.
    Engel, Samuel S.
    Kaufman, Keith D.
    Shankar, R. Ravi
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (04) : 693 - 699
  • [34] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
  • [35] Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
    Ballav, Chitrabhanu
    Gough, Stephen C. L.
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2013, 6 : 25 - 37
  • [36] Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
    Al Omari, Mousa
    Khader, Yousef
    Dauod, Ali Shakir
    Yonis, Othman Ahmed Beni
    Khassawneh, Adi Harbi Mohammad
    JOURNAL OF DRUG ASSESSMENT, 2016, 5 (01) : 29 - 33
  • [37] Efficacy and safety of canagliflozin in subjects with type 2 diabetes mellitus inadequately controlled with metformin plus sulphonylurea over 52 weeks
    Vercruysse, F.
    Charpentier, G.
    Wilding, J.
    Hollander, P.
    Gonzalez Galvez, G.
    Mathieu, C.
    Usiskin, K.
    Vijapurkar, U.
    Black, S.
    Canovatchel, W.
    Meininger, G.
    DIABETOLOGIA, 2013, 56 : S373 - S373
  • [38] Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study
    Seck, T.
    Nauck, M.
    Sheng, D.
    Sunga, S.
    Davies, M. J.
    Stein, P. P.
    Kaufman, K. D.
    Amatruda, J. M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 562 - 576
  • [39] Efficacy, Safety and Treatment Satisfaction of Glimepiride vs Sitagliptin in Combination with Metformin in Type 2 Diabetes Mellitus
    Kumar, Subodh
    Pathak, Anuj Kumar
    Saikia, Dibyajyoti
    Kumar, Amish
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2015, 9 (12) : FC07 - FC10
  • [40] Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)
    Rosenstock, Julio
    Frias, Juan
    Pall, Denes
    Charbonnel, Bernard
    Pascu, Raluca
    Saur, Didier
    Darekar, Amanda
    Huyck, Susan
    Shi, Harry
    Lauring, Brett
    Terra, Steven G.
    DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 520 - 529
12345